Stock Earnings

Question 1

What are Rapport Therapeutics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Rapport Therapeutics Inc has a total asset of $314, Net loss of $-78

Question 2

What are the key financial ratios for RAPP?

Accepted Answer

Rapport Therapeutics Inc's Current ratio is 34.88, has a Net margin is 0, sales per share of $0.

Question 3

How is Rapport Therapeutics Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Rapport Therapeutics Inc data is not available.

Question 4

Is Rapport Therapeutics Inc profitable?

Accepted Answer

no, according to the latest financial statements, Rapport Therapeutics Inc has a net loss of $-78

Question 5

Does Rapport Therapeutics Inc have any liabilities?

Accepted Answer

yes, Rapport Therapeutics Inc has liability of 9

Question 6

How many outstanding shares for Rapport Therapeutics Inc?

Accepted Answer

Rapport Therapeutics Inc has a total outstanding shares of 36.58

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022
Revenue	0	0	0	0
Revenue Growth (YoY)	--	--	--	--
Cost of Revenue	--	--	--	--
Gross Profit	--	--	--	--
Selling, General & Admin	26	22	8	1
Research & Development	74	60	27	9
Operating Expenses	101	83	36	10
Other Non Operating Income (Expenses)	--	-7	-1	--
Pretax Income	-88	-78	-34	-10
Income Tax Expense	--	0	0	--
Net Income	-88	-78	-34	-10
Net Income Growth	17%	129%	240%	--
Shares Outstanding (Diluted)	35.44	20.73	35.37	35.37
Shares Change (YoY)	-4%	-41%	0%	--
EPS (Diluted)	-2.5	-3.77	-0.98	-0.3
EPS Growth	23%	284%	227%	--
Free Cash Flow	-76	-67	-28	-3
Free Cash Flow Per Share	-2.14	-3.23	-0.79	-0.08
Gross Margin	--	--	--	--
Operating Margin	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%
EBITDA	-101	-83	-36	-10
EBITDA Margin	0%	0%	0%	0%
D&A For EBITDA	0	0	0	0
EBIT	-101	-83	-36	-10
EBIT Margin	0%	0%	0%	0%
Effective Tax Rate	--	0%	0%	--

Rapport Therapeutics Inc (RAPP) Price